Predicting Premature Treatment Termination in Inpatient Psychotherapy: A

Status Completed

Clinical Trial Summary

The study aims to develop a prediction model of premature treatment termination in psychosomatic hospitals using a machine learning approach.

Clinical Trial Description

The aim of the study is to identify risk factors that lead to or predict premature treatment termination in psychosomatic hospitals. In the long-term, the study shall help to develop more precise prediction models that can enhance communication between therapists and patients about potential dropout and- if necessary- adaption of treatment in using a feedback loop. Since it is still not clear which variables play a major role in predicting treatment termination in psychosomatic hospitals, the study design is exploratory and includes a broad range of intake patient characteristics. The purpose of this study is hereby, to develop a prediction model based on the information that are routinely assessed at intake. Therefore, three kind of variables are planned to be included: (1) demographic and other clinical variables (e.g. age, gender, ICD-10 diagnoses), (2) psychological questionnaire data (e.g. PHQ, SF-12, EB-45, IIP-32, OPD-SFK), and (3) physiological data (e.g. routine laboratory data, blood pressure). For the study, all patients that started inpatient psychotherapy at the medical centre Heidelberg between 2015 and January 2022 will be included, resulting in a sample size of approximately N = 2000. As the average dropout rate based on meta analytical results is around 20%, one can assume that up to 400 patients prematurely dropped out of treatment. To calculate the prediction model, it is planned to use a machine learning approach which is highly functional in big data sets. Using a Random Forest Model for binary outcomes (regular treatment length vs. premature treatment termination) it is envisioned to identify variables that contribute to the prediction of premature treatment termination at intake. Additionally, waiting list effects will be considered by taking into account the waiting duration between the initial intake interview and the moment of the hospital admission. Therefore, the study will, for the first time, investigate a prediction model for premature treatment termination in inpatient psychotherapy including clinically relevant physiological data as well as waiting time effects in preparation of the psychosomatic treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06042595
Study type	Observational
Source	University Hospital Heidelberg
Contact
Status	Completed
Phase
Start date	January 2015
Completion date	January 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05040958` - Carotid Atherosclerotic Plaque Load and Neck Circumference
Completed	`NCT04440553` - A Mobile App to Increase Physical Activity in Students	N/A
Completed	`NCT04977687` - Machine Learning Predict Renal Replacement Therapy After Cardiac Surgery
Completed	`NCT04828655` - Analysis of Bioparametric Measures for Correlating Daily Habits and Reducing Blood Pressure	N/A
Completed	`NCT04966598` - Machine Learning Predict Acute Kidney Injury in Patients Following Cardiac Surgery
Recruiting	`NCT06277297` - Prognotic Role of CMR in Takotsubo Syndrome
Recruiting	`NCT06204133` - Model Study on Cervical Cancer Screening Strategies and Risk Prediction
Completed	`NCT05085743` - Prediction of Endotracheal Tube Depth by Using Deep Convolutional Neural Networks
Not yet recruiting	`NCT05809232` - Impact of Machine Learning-based Clinician Decision Support Algorithms in Perioperative Care	N/A
Not yet recruiting	`NCT04399811` - Near-infrared Vision for Microcirculatory Status
Enrolling by invitation	`NCT05860777` - Harnessing Health IT to Promote Equitable Care for Patients With Limited English Proficiency and Complex Care Needs	N/A
Recruiting	`NCT05906719` - Machine Vision Based MDS-UPDRS III Machine Rating
Completed	`NCT06278272` - AI Evaluation of Pancreatic Exocrine Insufficiency in CP Patients
Withdrawn	`NCT05442762` - Social Media-based Vaccine Confidence and Hesitancy Monitoring
Not yet recruiting	`NCT05797064` - Establishment of a Feasibility Model for NOSE Surgery Based on Machine Learning
Recruiting	`NCT05410171` - Machine Learning-based Early Clinical Warning of High-risk Patients	N/A
Active, not recruiting	`NCT04192175` - Identification of Patients Admitted With COPD Exacerbations and Predicting Readmission Risk Using Machine Learning
Completed	`NCT05433519` - Diagnostic Accuracy of a Novel Machine Learning Algorithm to Estimate Gestational Age
Recruiting	`NCT05858892` - Comparison of an Artificial Intelligence-Assisted Rehabilitation Program for Shoulder Musculoskeletal Disorders and the Clinical Decision Making of Therapists
Completed	`NCT06208046` - Predict 5-Year Survival in Elderly Gastric Cancer

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Predicting Premature Treatment Termination in Inpatient Psychotherapy: A Machine Learning Approach

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms